The Ambulance Industry Nobody Watches — And the Public Company That Now Owns It

A private ambulance dealer in a small Pennsylvania town is about to unveil a new product. The bigger story is what it reveals about who actually makes the vehicles the American healthcare system depends on — and how you, as an investor, gain exposure to a market that the demographics say is only growing.

SIV Ambulances, a Langhorne, Pennsylvania company that has spent its life selling used ambulances and remounting old modules onto new chassis, is launching the SIV Responder and Responder XL — its own Type II ambulance models — at EMS World on September 30. It is an ambitious step for a business that works out of a 15,000-square-foot facility. You can't buy a share of it. It is private.

But what the move signals — and what matters for your portfolio — is the structural demand behind every ambulance that rolls off any assembly line in this country. The companies that serve this demand are consolidating at a pace that has quietly reshaped who owns the emergency vehicle industry. And the publicly traded entry point is not the small builder. It is the one that absorbed its competitors.

The demand that does not slow down

Here is the demographic arithmetic. The U.S. population aged 65 and older is projected to grow from about 58 million in 2022 to 77 million by 2034. Adults in that age bracket account for roughly a third of all 911 patient contacts. The 71-to-80 group alone generates about 8.5 million emergency responses per year. Nearly 95% of adults over 60 live with at least one chronic condition; 80% have two or more.

This is not a cyclical demand story. It is not a discretionary purchase. Ambulance fleets must be replaced whether GDP grows or shrinks. The U.S. ambulance services market is projected to reach $22.1 billion this year and expand to $25.9 billion by 2031. The global ambulance vehicle manufacturing market sits in the range of $2.5 billion to $22.6 billion depending on whether you count the vehicle alone or the vehicle plus equipment and services.

The demand has a floor. That matters. It means the businesses that build these vehicles sit closer to the real economy than most manufacturing names. They are not building for a trend. They are building for a population structure that is locked in for the next two decades.

The consolidation that reshaped the industry

The supply side of this market has changed dramatically — and quietly. The two biggest movements happened within the last year.

Terex Corporation, a construction equipment manufacturer, completed its merger with REV Group on February 2, 2026. REV Group built fire apparatus, ambulances, waste collection vehicles, and recreational vehicles under a dozen brand names. The combined company now operates across emergency services, waste and recycling, utilities, and construction. Terex trades at a $6.95 billion market cap, with an enterprise value of $9.23 billion. It expects to unlock $75 million in annualized run-rate synergies by 2028.

Then there is J.B. Poindexter & Co., a private commercial vehicle manufacturing conglomerate, which acquired Demers Braun Crestline Medix — one of North America's largest ambulance manufacturers, with over 70,000 units delivered and more than 1,500 employees. The deal was expected to push JBPCO's total revenue to $3 billion. The CEO called it a "colossal risk" but noted that moving during uncertain times is central to the company's strategy.

The pattern is clear. The emergency vehicle industry is consolidating. Scale matters because it gives buyers — municipalities, fire departments, private EMS operators — a single point for manufacturing, parts, service, and financing. Small independent manufacturers compete on customization and local relationships. But the structural trend favors the platforms that can offer the full lifecycle.

Where you actually invest in this story

Since SIV Ambulances is private, the question for you is not whether to buy its stock — it is whether the publicly traded players in this ecosystem represent a durable, income-generating investment in a structurally growing market.

Terex, now the combined entity, is the most direct public exposure to the emergency vehicle manufacturing side of this market. The numbers warrant scrutiny.

The company trades at a forward P/E of 37.4 and a P/E based on the last twelve months of 46.6. That is expensive for a specialty equipment manufacturer. Enterprise value to EBITDA sits at 14.8x, and the price-to-sales ratio is 1.04. The valuation reflects the merger premium and market optimism about the combined platform's resilience.

The dividend profile, however, is not speculative. Terex has paid dividends for 12 consecutive years, with four consecutive years of growth. The current yield sits near 1%, and the trailing twelve-month payout ratio is about 48%. Free cash flow over the past year came in at $339 million against operating cash flow of $456 million. FCF grew 43.6% year over year. The balance sheet carries $5.4 billion in total debt, but debt-to-equity sits at 0.55, the current ratio is 1.82, and the company holds $407 million in cash.

This is a company that can fund its payout — but the 1% yield is not an income story on its own. The investment case here is not current income. It is whether the combined platform — fire apparatus, ambulances, waste vehicles, and construction equipment — can deliver earnings growth that grows that dividend over time. The demographic tailwind on the ambulance and fire side supports that thesis. The question is whether the current multiple already assumes it.

At a forward multiple of 37, the market is pricing in significant growth. That does not mean the investment is bad. It means the margin for error is narrower. If inflation runs structurally higher — as I believe it may, given deglobalization, demographics, energy transition, and fiscal dominance — companies with pricing power in mission-critical equipment can pass costs through. But the premium valuation requires that earnings actually compound at a rate that justifies what the market is asking today.

What the small player tells us

SIV Ambulances entering new manufacturing tells us something about the market structure. There is still room at the edges for specialized, lower-cost alternatives. Type II ambulances — van-based platforms designed for urban environments — represent a specific niche. Ambulance vans represent a substantial share of the ambulance vehicle market. A small Pennsylvania shop can compete on price, speed, and local relationships.

But for the investor, the lesson is about where scale goes. The consolidation into Terex and into JBPCO's private empire suggests that the large contracts, the institutional buyers, and the full-service platforms are gravitating toward the giants. The small players survive in niches. The investors capture the market through the consolidators.

The investment frame

The emergency vehicle industry is one of those overlooked corners of the real economy — a "TOLL" stock sector, in the language of businesses that the economy cannot function without. The demand is structural, not cyclical. The consolidation is creating larger, more diversified platforms with more resilient top lines.

The publicly traded entry — Terex — is a diversified specialty equipment company, not a pure-play ambulance story. That diversification is both a strength and a dilution. The ambulance and fire segment adds resilience to a construction machinery core, but you are buying the whole platform. The valuation reflects that combination.

This is not a stock you buy for yield. At 1%, it does not move the needle in a retirement-income sleeve on its own. The case is whether you believe a consolidated specialty equipment manufacturer, sitting on demand that grows from demographics rather than consumer sentiment, can compound earnings — and therefore dividends — over the next decade. The 48% payout ratio and $339 million in free cash flow say the company has room. The 37x forward multiple says the market already expects a lot from it.

The better question may not be whether to buy Terex today at this price, but whether to watch it as a proxy for the consolidation that is reshaping the industries we need but rarely think about. The ambulance that rolls out of a Pennsylvania workshop and the fire apparatus built in Wisconsin both serve the same invisible demographic curve. The investors who own the platforms that build them will benefit from a demand that, once again, is not a trend — it is a lock.